CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Tate & Lyle›
News
Tate & Lyle

Tate & Lyle

Tate & Lyle supplies sweeteners, starches, fibres, texturants, and hydrocolloid ingredient solutions to food and beverage manufacturers worldwide.

London, GB🇬🇧
Founded
1921
Loading
Overview
M & A
Compare
Employees
News
Library

Latest News About Tate & Lyle

Tate & Lyle and BioHarvest reach key milestone in next-generation sweetener development programme

Tate & Lyle

Tate & Lyle and BioHarvest reach key milestone in next-generation sweetener development programme

Progress demonstrates that BioHarvest’s Botanical Synthesis™ platform is capable of producing the targeted next-generation sweetening...

Oct 8, 2026

Tate & Lyle named on TIME and Statista’s World’s Best Companies 2026 list

Tate & Lyle

Tate & Lyle named on TIME and Statista’s World’s Best Companies 2026 list

Tate & Lyle is one of around 50 food and drink businesses recognised in TIME Magazine and Statista’s list for 2026

Sep 10, 2026

Tate & Lyle strengthens climate ambition with updated science-based targets to reduce greenhouse gas emissions

Tate & Lyle

Tate & Lyle strengthens climate ambition with updated science-based targets to reduce greenhouse gas emissions

Updated targets reflect Tate & Lyle’s expanded footprint following the acquisition of CP Kelco in 2024 and its commitment to building a...

Sep 2, 2026

Tate & Lyle adds new purpose target to improve everyday consumer health through fibre fortification

Tate & Lyle

Tate & Lyle adds new purpose target to improve everyday consumer health through fibre fortification

Ambitious new target aims to reach 35 billion ‘daily fibre gap equivalent’ servings by 31 March 2030

Aug 26, 2026

Results of Shareholder Meetings

Tate & Lyle

Results of Shareholder Meetings

Read the results of Shareholder Meetings

Jul 28, 2026

Consumers look beyond sugar reduction as focus on metabolic health grows, says Tate & Lyle report

Tate & Lyle

Consumers look beyond sugar reduction as focus on metabolic health grows, says Tate & Lyle report

Future-Proofing Nutrition report explores the role of reformulation, fibre fortification and blood glucose management in supporting...

Jul 21, 2026